Dr Alok Chaturvedi INTAS Pharma

Intas launches the World’s First SB-100mg Itraconazole

Intas launches the World’s First SB-100mg Itraconazole

This medical breakthrough will significantly reduce cost and increase compliance in patients undergoing Antifungal Therapy Ahmedabad (Gujarat) [India], October 16: One of the world’s leading pharmaceutical companies, Intas Pharmaceuticals, has made a progressive breakthrough in the Antifungal Therapy domain with the launch of the world’s first Super Bioavailable Itraconazole-SB 100mg by the Brand Name of Itaspor-SB Forte/Subawin. It has been recently approved by Indian Regulatory Authorities. Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage, antacids consumption etc. and overall cost of treatment. Itaspor SB…
Read More